Auditing Excellence: Enhancing Internal and External Audits with an EQMS

In an era defined by heightened regulatory scrutiny, accelerating technology capability, and the permanent normalization of remote inspection, the quality audit function has evolved from a compliance exercise into a strategic organizational capability. This white paper, "Auditing Excellence: Enhancing Internal and External Audits with an eQMS," provides a comprehensive guide for organizations seeking to build audit programs that satisfy 2026 regulatory expectations while delivering the operational efficiency and risk intelligence that modern quality management demands.

The regulatory context has changed fundamentally since the original publication of this white paper. The FDA QMSR, effective February 2, 2026, replaced the decades-old Quality System Regulation and aligned U.S. medical device audit requirements with ISO 13485:2016. The new FDA inspection approach under Compliance Program 7382.850 replaced the QSIT methodology and expanded inspector access to internal audit records and supplier audit evidence. EU MDR and IVDR continue to demand rigorous notified body oversight. MDSAP provides a pathway to satisfy five global regulatory frameworks through a single audit. And the EU MedTech industry has formally called for EU full MDSAP membership, which would expand the program to six jurisdictions.

Against this backdrop, eQMS platforms have emerged as the operational infrastructure that makes modern audit programs possible. This white paper explores that infrastructure, providing practical frameworks, updated metrics, and implementation guidance for quality organizations ready to elevate their audit function from reactive compliance management to proactive quality intelligence.